低剂量氯胺酮在疼痛性骨科手术中的系统综述与荟萃分析
该系统综述与荟萃分析纳入20项随机对照试验,评估低剂量氯胺酮对比安慰剂在重大疼痛性骨科手术中的镇痛效果。结果显示低剂量氯胺酮显著减少总阿片类药物用量、降低24和48小时VAS疼痛评分并延迟首次阿片需求时间,全关节手术中效果最明显,证据质量中等。
要点
- 低剂量氯胺酮可减少骨科手术患者阿片用量并降低24-48小时疼痛评分。
- 全关节手术中效果最显著,恶心呕吐与幻觉结果不一致。
- 对慢性疼痛的影响尚无定论,未来需关注关节镜手术与慢性疼痛。
核心结论
- 低剂量氯胺酮是疼痛性骨科手术的有效辅助药物,可降低疼痛和阿片需求,尤其术后24小时内。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、Embase、Cochrane及专业期刊的随机对照试验,比较低剂量氯胺酮与安慰剂,纳入20项研究分四个亚组。
主要发现
- 恶心和幻觉的结果不一致,慢性疼痛的结果无定论,全关节手术中效果最显著。
关键数值与推荐
- 证据总体质量中等(GRADE评级)。
临床怎么用
- 可考虑将低剂量氯胺酮作为疼痛性骨科手术的辅助镇痛手段,尤其关注术后24小时内的阿片节约与疼痛控制。
局限性
- 证据质量中等,恶心呕吐与幻觉结果不一致,慢性疼痛影响无定论,未来需聚焦关节镜手术与慢性疼痛发生率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ketamine is a phencyclidine intravenous anaesthetic that blocks N-methyl-d-aspartate receptors and HCN channels in the CNS. Lately it has gained acceptance in a low-dose form, with studies showing an analgesic benefit in orthopaedic surgery. Our goal was to critically appraise and synthesise current evidence regarding use of low-dose ketamine in major, painful orthopaedic surgeries. METHODS: We conducted searches in Medline, Embase, Cochrane, and specialty journals for randomised controlled trials (RCTs) that compared low-dose ketamine to placebo. Primary outcomes included total opioid use, time to first opioid, and VAS pain scores. Meta-analyses were undertaken in RevMan software using a random effects model. We rated the quality of the evidence using the GRADE Working Group criteria. RESULTS: We included 20 studies across four subgroups for meta-analysis. The overall quality of the evidence was moderate. Ketamine significantly decreased total opioid use and pain scores (VAS) at 24 and 48 h (Opioid: standardised mean difference [SMD] -0.82 [-1.24, -0.40], p=0.0001, and -0.65 [-1.03,-0.27], p=0.0008; VAS: SMD -0.53 [-0.91, -0.15], p=0.006 and -0.60 [-1.05, -0.16], p=0.008), and delayed the time to first opioid dose (SMD 0.64 [0.01, 1.27], p=0.05). Results for nausea and hallucinations were equivocal, whereas results for chronic pain were inconclusive. The most prominent effects were seen in total joint operations. CONCLUSION: Low-dose ketamine is an effective adjuvant that decreases pain and opioid requirements in painful orthopaedic procedures, especially in the first 24 h after procedure. Future research should focus on arthroscopic procedures and the incidence of chronic pain.
引用
- Riddell JM, Trummel JM, Onakpoya IJ, et al. Low-dose ketamine in painful orthopaedic surgery: a systematic review and meta-analysis. Br J Anaesth. 2019. PMID: 31327465. doi:10.1016/j.bja.2019.05.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。